NO975076L - Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling - Google Patents

Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling

Info

Publication number
NO975076L
NO975076L NO975076A NO975076A NO975076L NO 975076 L NO975076 L NO 975076L NO 975076 A NO975076 A NO 975076A NO 975076 A NO975076 A NO 975076A NO 975076 L NO975076 L NO 975076L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparation
thiagabine
hydrochloride
thiagabine hydrochloride
Prior art date
Application number
NO975076A
Other languages
English (en)
Other versions
NO318599B1 (no
NO975076D0 (no
Inventor
Joergen Ryhl Svensson
Lars Nygaard
Tina Meinertz Andersen
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO975076L publication Critical patent/NO975076L/no
Publication of NO975076D0 publication Critical patent/NO975076D0/no
Publication of NO318599B1 publication Critical patent/NO318599B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO19975076A 1995-05-05 1997-11-04 Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling NO318599B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05
PCT/DK1996/000192 WO1996034606A1 (en) 1995-05-05 1996-04-29 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Publications (3)

Publication Number Publication Date
NO975076L true NO975076L (no) 1997-11-04
NO975076D0 NO975076D0 (no) 1997-11-04
NO318599B1 NO318599B1 (no) 2005-04-18

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975076A NO318599B1 (no) 1995-05-05 1997-11-04 Farmasoytisk preparat som inneholder tiagabin og fremgangsmate for dets fremstilling

Country Status (26)

Country Link
US (1) US5866590A (no)
EP (1) EP0830132B1 (no)
JP (1) JP3195360B2 (no)
KR (1) KR100440354B1 (no)
CN (1) CN1092959C (no)
AR (1) AR003418A1 (no)
AT (1) ATE211911T1 (no)
AU (1) AU707508B2 (no)
BR (1) BR9608120A (no)
CA (1) CA2220019C (no)
CZ (1) CZ292256B6 (no)
DE (1) DE69618586T2 (no)
DK (1) DK0830132T3 (no)
EG (1) EG23781A (no)
ES (1) ES2171669T3 (no)
HU (1) HU223075B1 (no)
IL (1) IL118142A (no)
MX (1) MX9708394A (no)
MY (1) MY115016A (no)
NO (1) NO318599B1 (no)
NZ (1) NZ307159A (no)
PL (1) PL183678B1 (no)
PT (1) PT830132E (no)
UA (1) UA43402C2 (no)
WO (1) WO1996034606A1 (no)
ZA (1) ZA963478B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
AU8643698A (en) * 1997-08-01 1999-02-22 Elan Corporation, Plc Controlled release pharmaceutical compositions containing tiagabine
WO1999017771A1 (en) * 1997-10-02 1999-04-15 H. Lundbeck A/S Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2001260083A1 (en) 2000-05-26 2001-12-03 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
SG11201407309XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy
JP6793651B2 (ja) * 2015-08-28 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
AR003418A1 (es) 1998-08-05
HU223075B1 (hu) 2004-03-01
JP3195360B2 (ja) 2001-08-06
DK0830132T3 (da) 2002-04-29
EG23781A (en) 2007-08-13
PL323138A1 (en) 1998-03-16
UA43402C2 (uk) 2001-12-17
PL183678B1 (pl) 2002-06-28
PT830132E (pt) 2002-07-31
CZ338897A3 (cs) 1998-03-18
CN1183721A (zh) 1998-06-03
KR100440354B1 (ko) 2004-09-18
MY115016A (en) 2003-03-31
BR9608120A (pt) 1999-02-09
EP0830132A1 (en) 1998-03-25
ZA963478B (en) 1996-11-13
DE69618586T2 (de) 2002-09-05
HUP9802741A2 (hu) 1999-03-29
NO318599B1 (no) 2005-04-18
CA2220019A1 (en) 1996-11-07
IL118142A (en) 1999-11-30
DE69618586D1 (de) 2002-02-21
CZ292256B6 (cs) 2003-08-13
IL118142A0 (en) 1996-09-12
US5866590A (en) 1999-02-02
EP0830132B1 (en) 2002-01-16
ATE211911T1 (de) 2002-02-15
ES2171669T3 (es) 2002-09-16
WO1996034606A1 (en) 1996-11-07
AU707508B2 (en) 1999-07-15
JPH10505359A (ja) 1998-05-26
MX9708394A (es) 1998-02-28
NZ307159A (en) 1998-10-28
CA2220019C (en) 2007-12-11
NO975076D0 (no) 1997-11-04
AU5644196A (en) 1996-11-21
CN1092959C (zh) 2002-10-23
HUP9802741A3 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
NO974685L (no) Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
DK0739898T3 (da) Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf
EE9700232A (et) Olansapiini polümorfne vorm II, selle saamismeetod ja farmatseutiline preparaat
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
HUP9802694A3 (en) Benzamide derivatives, process for producing them and pharmaceutical compositions containing them
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
NO924768D0 (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
NO973612D0 (no) Nytt farmasöytisk preparat
DK0766666T3 (da) Benzylsulfidderivat, fremgangsmåde til dets fremstilling og pesticid
HUP0102292A3 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
NO961000D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NO975076D0 (no) Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling
NO960722L (no) Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
NO20001288L (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
NO974934D0 (no) 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO973610D0 (no) Nytt farmasöytisk preparat
IS5270A (is) (R)-3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíðhýdrógentartrat, aðferðvið framleiðslu þess og lyfjablöndur sem innihalda það
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees